IHS Chemical Week

Regions :: Western Europe :: Austria

Lonza and Novartis Jointly to Develop and Manufacture Biologics Products

7:47 AM MDT | July 11, 2008 | Deepti Ramesh

Lonza says it has entered into a long-term strategic partnership with Novartis for the joint development and manufacture of Novartis's biologics pipeline. R&D activities over the past few years have resulted in a sharp increase in the number of biological compounds, currently accounting for about a quarter of the Novartis development portfolio, Novartis says. The biologics unit of Novartis aims to further grow the biologics pipeline. Lonza will be involved in the development, scale-up and manufacturing of Novartis' biologics pipeline. Lonza will provide...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa